PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Adiponutrin/patatin-like phospholipase-3 (PNPLA3) I148M transgenic mice were used as a model of NAFLD [25] to investigate the lipid-lowering effect of CS-LPNs.